Pub. Date : 2021 Jun 20
PMID : 34203048
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Dipeptidyl peptidase-4 (DPP-4) is a therapeutic target for the management of T2DM, and its inhibitors prevent the degradation of glucose-dependent insulinotropic peptide and glucagon-like peptide 1, and thus, maintain their endogenous levels and lower blood glucose levels. | Glucose | dipeptidyl peptidase 4 | Homo sapiens |
2 | Dipeptidyl peptidase-4 (DPP-4) is a therapeutic target for the management of T2DM, and its inhibitors prevent the degradation of glucose-dependent insulinotropic peptide and glucagon-like peptide 1, and thus, maintain their endogenous levels and lower blood glucose levels. | Glucose | dipeptidyl peptidase 4 | Homo sapiens |
3 | Dipeptidyl peptidase-4 (DPP-4) is a therapeutic target for the management of T2DM, and its inhibitors prevent the degradation of glucose-dependent insulinotropic peptide and glucagon-like peptide 1, and thus, maintain their endogenous levels and lower blood glucose levels. | Glucose | dipeptidyl peptidase 4 | Homo sapiens |
4 | Dipeptidyl peptidase-4 (DPP-4) is a therapeutic target for the management of T2DM, and its inhibitors prevent the degradation of glucose-dependent insulinotropic peptide and glucagon-like peptide 1, and thus, maintain their endogenous levels and lower blood glucose levels. | Glucose | dipeptidyl peptidase 4 | Homo sapiens |